Global Hemorrhoid Treatment Devices Market Size By Type (Band Ligators, Sclerotherapy Injectors), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Hemorrhoid Treatment Devices Market was valued at USD 620 million in 2023 and is projected to reach USD 1.12 billion by 2031, growing at a CAGR of 7.8% during the forecast period from 2023 to 2031. This growth is driven by the increasing prevalence of hemorrhoidal disorders, rising geriatric population, and the growing adoption of minimally invasive procedures. As patients seek effective, less painful treatment alternatives with quicker recovery times, demand for innovative hemorrhoid treatment devices continues to surge across both developed and developing regions.

Drivers

1. Increasing Prevalence of Hemorrhoids:

Rising incidences of hemorrhoids, fueled by sedentary lifestyles, poor dietary habits, and chronic constipation, are significantly contributing to the growing need for advanced treatment options.

2. Growing Preference for Minimally Invasive Treatments:

The shift towards less invasive procedures such as infrared coagulation, bipolar therapy, and laser-based treatments is accelerating market expansion, especially in outpatient and ambulatory settings.

3. Expanding Geriatric Population:

The global aging population is more susceptible to hemorrhoidal disorders due to age-related weakening of rectal tissues, thereby driving demand for effective treatment devices.

Restraints

1. High Cost of Advanced Devices:

The high initial costs associated with hemorrhoid treatment devices, particularly laser and doppler-guided systems, can limit adoption in low- and middle-income countries.

2. Limited Awareness in Emerging Economies:

Lack of awareness about advanced treatment options and availability of traditional remedies can hamper market growth in certain regions.

Opportunity

1. Rising Medical Tourism in Emerging Markets:

Countries such as India, Thailand, and Mexico are witnessing a boom in medical tourism, offering cost-effective hemorrhoid treatments with advanced technology, creating substantial growth potential.

2. Technological Innovations in Device Design:

The integration of ergonomic and compact designs, as well as the introduction of disposable and single-use devices, presents new opportunities for players to address infection control concerns and improve patient safety.

Market by System Type Insights

Based on system type, the Non-surgical Hemorrhoid Treatment Devices segment dominated the market in 2023. Devices such as rubber band ligators and infrared coagulators are widely adopted due to their effectiveness, minimal downtime, and suitability for outpatient procedures. The Minimally Invasive Surgical Devices segment is projected to witness the fastest growth, driven by increasing adoption of procedures like Doppler-guided hemorrhoidal artery ligation (DGHAL) and laser hemorrhoidoplasty.

Market by End-use Insights

By end-use, Hospitals accounted for the largest market share in 2023, owing to the availability of skilled professionals and advanced treatment infrastructure. However, Ambulatory Surgical Centers (ASCs) are expected to grow at the fastest pace during the forecast period, supported by a shift toward outpatient care and cost-efficient treatment models.

Market by Regional Insights

Geographically, North America led the market in 2023, driven by a high prevalence of lifestyle-related diseases, favorable reimbursement policies, and technological advancements. Asia-Pacific is poised to be the fastest-growing region, attributed to improving healthcare infrastructure, increasing disposable incomes, and a surge in demand for minimally invasive hemorrhoid treatments.

Competitive Scenario

Key players in the Global Hemorrhoid Treatment Devices Market include:

Medtronic plc

Cook Medical

Boston Scientific Corporation

Medline Industries, LP

The Prometheus Group

Sklar Surgical Instruments

Integra LifeSciences Corporation

These companies are focusing on product innovation, strategic partnerships, and regional expansion to strengthen their global footprint. Notable developments include:

2023: Medtronic launched an advanced laser-based hemorrhoid treatment system targeting outpatient surgery centers.

2024: Boston Scientific entered into a strategic alliance with a healthcare provider network to supply Doppler-guided hemorrhoid ligation systems in North America.

2025: Cook Medical expanded its portfolio by acquiring a startup specializing in single-use ligation devices for enhanced infection control.

Scope of Work – Global Hemorrhoid Treatment Devices Market

Report Metric Details

Market Size (2023) USD 620 million

Projected Market Size (2031) USD 1.12 billion

CAGR (2023–2031) 7.8%

Market Segments System Type, End-use, Region

Growth Drivers Rising prevalence, minimally invasive devices, aging population

Opportunities Emerging markets, device innovation

Key Market Developments

Medtronic (2023): Released a compact, laser-based hemorrhoid treatment tool designed for outpatient settings.

Boston Scientific (2024): Collaborated with hospitals to provide bundled hemorrhoid care solutions with Doppler technology.

Integra LifeSciences (2025): Unveiled a range of ergonomic hemorrhoidectomy devices targeting high-precision surgical outcomes.

FAQs

What is the current market size of the Global Hemorrhoid Treatment Devices Market?

The market size was USD 620 million in 2023.

What is the major growth driver of the Global Hemorrhoid Treatment Devices Market?

The growing preference for minimally invasive procedures is the key driver.

Which is the largest region during the forecast period in the Global Hemorrhoid Treatment Devices Market?

North America holds the largest market share.

Which segment accounted for the largest market share in the Global Hemorrhoid Treatment Devices Market?

The Non-surgical Hemorrhoid Treatment Devices segment led in 2023.

Who are the key market players in the Global Hemorrhoid Treatment Devices Market?

Medtronic, Cook Medical, Boston Scientific, and Medline Industries are among the key players.